Protein Tyrosine Phosphatase 1B (PTP1B) Deficiency Substantially Attenuates Glomerular Injury in Endothelial Nitric

Daisuke Katagiri1, Shinya Nagasaka1, Keiko Takahashi1

  • 1Nephrology, Vanderbilt University Medical Center, Nashville, USA.

Cureus
|March 3, 2025
PubMed

Insights

Endothelial nitric oxide synthase (eNOS) deficiency worsens diabetic nephropathy (DN) by activating protein tyrosine phosphatase 1B (PTP1B). However, PTP1B deficiency significantly reduces glomerular injury in diabetic eNOS knockout mice.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Endothelial nitric oxide synthase (eNOS) deficiency exacerbates diabetic nephropathy (DN), but mechanisms remain unclear.
  • Nitric oxide inactivates protein tyrosine phosphatase 1B (PTP1B), a key negative regulator of insulin signaling.
  • We hypothesized eNOS deficiency activates PTP1B, impairing insulin signaling and worsening kidney injury in DN.

Purpose of the Study:

  • To investigate the role of PTP1B in eNOS deficiency-driven diabetic nephropathy.
  • To determine if PTP1B deficiency ameliorates glomerular injury in the absence of eNOS.

Main Methods:

  • Generated and analyzed PTP1B/eNOS double knockout (DKO) mice compared to eNOS knockout (KO) mice.
  • Induced diabetes using streptozotocin and performed phenotypic analyses at 10 and 22 weeks.
  • Utilized histological, immunofluorescence, and immunohistochemical methods to assess glomerular injury and podocyte markers.

Main Results:

  • Diabetic DKO mice showed significantly reduced albuminuria compared to diabetic eNOS KO mice.
  • Histological analysis revealed milder mesangial expansion and mesangiolysis in DKO mice.
  • DKO mice exhibited higher podocyte numbers, increased nephrin expression, elevated spliced X-box binding protein 1 (sXBP-1), and decreased C/EBP-homologous protein (CHOP) in podocytes.

Conclusions:

  • PTP1B deficiency substantially mitigates glomerular injury in diabetic mice lacking eNOS.
  • Enhanced insulin signaling and improved podocyte endoplasmic reticulum (ER) stress are potential mechanisms underlying this renoprotective effect.